跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-RIZATRIPTAN ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-RIZATRIPTAN ODT
Authorized
STANDARD
ACCEL-RIZATRIPTAN ODT
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0dd347be4061c9e6
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
0dd347be4061c9e6
Drug Approval Canada Name
ACCEL-RIZATRIPTAN ODT
Product Name
ACCEL-RIZATRIPTAN ODT
Status
Marketed
Status Date
2019-10-07
Original Market Date
2019-10-07
Din
02483270
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC04 RIZATRIPTAN
Atc Name
n 02 cc 04
Aig Number
0137841001
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0dd347be4061c9e6
Type
Standard
Back to Health Canada Approvals